Elmwood Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$31K Hold
125
0.02% 193
2021
Q1
$31K Buy
+125
New +$29.8K 0.02% 186
2020
Q3
$29K Hold
122
0.02% 145
2020
Q2
$29K Buy
122
+14
+13% +$3.19K 0.02% 145
2020
Q1
$18.5K Buy
+108
New +$23.6K 0.02% 163
2019
Q4
Sell
-112
Closed -$22K 98
2019
Q3
$22K Buy
112
+1
+0.9% +$192 0.02% 138
2019
Q2
$21K Hold
111
0.02% 156
2019
Q1
$21K Buy
111
+1
+0.9% +$191 0.02% 153
2018
Q4
$21K Hold
110
0.02% 154
2018
Q3
$22.7K Buy
110
+1
+0.9% +$197 0.02% 166
2018
Q2
$20.1K Buy
109
+1
+0.9% +$177 0.02% 169
2018
Q1
$18.5K Buy
+108
New +$19.8K 0.02% 163

Other funds holding AMGN

Elmwood Wealth Management's AMGN Position: Q2 2021 in Review

Elmwood Wealth Management held its Amgen (AMGN) position steady in Q2 2021 at 125 shares worth $31K. The position accounts for 0.02% of the portfolio, ranked #193.

Elmwood Wealth Management first reported a position in AMGN in Q1 2018 and has held it in 12 quarters since. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Elmwood Wealth Management held 125 shares of Amgen worth $31K as of Q2 2021.
  • Elmwood Wealth Management left its Amgen share count unchanged in Q2 2021.
  • Amgen made up 0.02% of Elmwood Wealth Management's portfolio in Q2 2021, its #193 holding.
  • Elmwood Wealth Management first reported a position in Amgen in Q1 2018 and has held it in 12 quarters since.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Elmwood Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.